Synergistic antinociceptive effects of concomitant NAAA and peripheral FAAH inhibition

Exp Neurol. 2022 Nov:357:114194. doi: 10.1016/j.expneurol.2022.114194. Epub 2022 Aug 4.

Abstract

The intracellular lipid amidases, fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amidase (NAAA), terminate the actions of anandamide and palmitoylethanolamide (PEA), two antinociceptive and anti-inflammatory lipid-derived mediators. Here we show, confirming prior research, that small-molecule inhibitors of peripheral FAAH (compound URB937) and systemic NAAA (compound ARN19702) individually attenuate, in male CD-1 mice, pain-related behaviors and paw inflammation in the formalin and carrageenan tests. More importantly, isobolographic analyses revealed that the combination of URB937 and ARN19702 produced substantial synergistic (greater than additive) antinociceptive effects in both models as well as additive anti-inflammatory effects in the carrageenan test. Together, the findings uncover a functional interplay between FAAH and NAAA substrates in the control of nociception, which might be exploited clinically to develop safe and effective pain management strategies.

Keywords: ARN19702; FAAH; Isobolographic analysis; NAAA; Pain; URB937.

MeSH terms

  • Amidohydrolases*
  • Analgesics / pharmacology
  • Analgesics / therapeutic use
  • Animals
  • Anti-Inflammatory Agents* / pharmacology
  • Carrageenan
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Male
  • Mice

Substances

  • Analgesics
  • Anti-Inflammatory Agents
  • Enzyme Inhibitors
  • Carrageenan
  • Amidohydrolases
  • fatty-acid amide hydrolase
  • amidase